Expanding Donor Pool for Liver Transplantation by Utilizing Hepatitis C Virus-Infected Donors for Uninfected Recipients
- PMID: 29672899
- PMCID: PMC6675396
- DOI: 10.1002/hep.30043
Expanding Donor Pool for Liver Transplantation by Utilizing Hepatitis C Virus-Infected Donors for Uninfected Recipients
Conflict of interest statement
Potential conflict of interest: Dr. Ahmed consults for, advises for, and received grants from Gilead and Intercept. He consults for and advises for AbbVie, Jensen, and Shire.
Comment in
-
Reply.Hepatology. 2018 Aug;68(2):793. doi: 10.1002/hep.30042. Hepatology. 2018. PMID: 29672882 No abstract available.
Comment on
-
Transplanting hepatitis C virus-positive livers into hepatitis C virus-negative patients with preemptive antiviral treatment: A modeling study.Hepatology. 2018 Jun;67(6):2085-2095. doi: 10.1002/hep.29723. Epub 2018 Apr 19. Hepatology. 2018. PMID: 29222916 Free PMC article.
References
-
- Cholankeril G, Li AA, March KL, et al. Improved outcomes in HCV patients following liver transplantation during the era of direct-acting antiviral agents. Clin Gastroenterol Hepatol 2018;16:452–453. - PubMed
-
- Cholankeril G, Li AA, Yoo ER, Ahmed A. Direct-acting antiviral therapy and improvement in graft survival of hepatitis C liver transplant recipients. Transplantation 2017;101:e349. - PubMed
-
- Verna EC, Goldberg DS. Hepatitis C viremic donors for hepatitis C nonviremic liver transplant recipients: ready for prime time? Liver Transpl 2018;24:12–14. - PubMed
-
- Cholankeril G, Ahmed A. Alcoholic liver disease replaces hepatitis C virus infection as the leading indication for liver transplantation in the United States. Clin Gastroenterol Hepatol 2017. December 1 pii: S1542–3565(17)31418–0. doi: 10.1016/j.cgh.2017.11.045 [Epub ahead of print] - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical